Zai Lab Ltd

Common Name
Zai Lab
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
1,869
Ticker
9688
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Zai Lab Limited is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies for oncology, autoimmune, infectious, and neurological diseases. Headquarte...

Financial Statements of Zai Lab

Below are the financial statements of Zai Lab, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of USD20242023
Revenues
Product revenue, net
397.61a
266.72a
Collaboration revenue
1.37a
0a
Total revenues
398.99a
266.72a
Expenses
Cost of product revenue
-147.12a
-95.82a
Cost of collaboration revenue
-0.74a
0a
Research and development
-234.5a
-265.87a
Selling, general and administrative
-298.74a
-281.61a
Gain on sale of intellectual property
0a
10a
Loss from operations
-282.12a
-366.57a
Interest income
37.11a
39.8a
Interest expenses
-2.25a
0a
Foreign currency losses
-15.14a
-14.85a
Other income, net
5.3a
7.01a
Loss before income tax
-257.1a
-334.62a
Income tax expense
0a
0a
Net loss
-257.1a
-334.62a

Verified Sources Behind Zai Lab’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Zai Lab’s data sources below and access millions more through our Disclosure Search.

a. Zai Lab's Annual Report 2024
Trace every data point back to Zai Lab’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?